Mersana Therapeutics Inc. (NASDAQ:MRSN) went down by -12.58% from its latest closing price compared to the recent 1-year high of $15.41. The company’s stock price has collected -28.03% of loss in the last five trading sessions.
Is It Worth Investing in Mersana Therapeutics Inc. (NASDAQ :MRSN) Right Now?
Plus, the 36-month beta value for MRSN is at 2.34. Opinions of the stock are interesting as 5 analysts out of 7 who provided ratings for Mersana Therapeutics Inc. declared the stock was a “buy,” while 1 rated the stock as “overweight,” 1 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $16.67, which is $18.15 above the current price. MRSN currently public float of 53.31M and currently shorts hold a 8.03% ratio of that float. Today, the average trading volume of MRSN was 1.60M shares.
MRSN’s Market Performance
MRSN stocks went down by -28.03% for the week, with a monthly drop of -34.63% and a quarterly performance of -41.24%, while its annual performance rate touched -80.36%. The volatility ratio for the week stands at 11.64% while the volatility levels for the past 30 days are set at 10.41% for Mersana Therapeutics Inc.. The simple moving average for the period of the last 20 days is -26.32% for MRSN stocks with a simple moving average of -60.14% for the last 200 days.
Analysts’ Opinion of MRSN
Many brokerage firms have already submitted their reports for MRSN stocks, with BTIG Research repeating the rating for MRSN by listing it as a “Buy.” The predicted price for MRSN in the upcoming period, according to BTIG Research is $32 based on the research report published on October 15th of the previous year 2021.
H.C. Wainwright, on the other hand, stated in their research note that they expect to see MRSN reach a price target of $28. The rating they have provided for MRSN stocks is “Buy” according to the report published on August 30th, 2021.
Credit Suisse gave a rating of “Neutral” to MRSN, setting the target price at $18 in the report published on March 31st of the previous year.
MRSN Trading at -30.02% from the 50-Day Moving Average
After a stumble in the market that brought MRSN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -81.51% of loss for the given period.
Volatility was left at 10.41%, however, over the last 30 days, the volatility rate increased by 11.64%, as shares sank -28.57% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -39.10% lower at present.
During the last 5 trading sessions, MRSN fell by -28.03%, which changed the moving average for the period of 200-days by -75.47% in comparison to the 20-day moving average, which settled at $3.81. In addition, Mersana Therapeutics Inc. saw -54.18% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at MRSN starting from Carvajal Alejandra, who sale 3,948 shares at the price of $3.69 back on Apr 26. After this action, Carvajal Alejandra now owns 9,302 shares of Mersana Therapeutics Inc., valued at $14,568 using the latest closing price.
Hack Andrew A. F., the Director of Mersana Therapeutics Inc., purchase 617,284 shares at $4.05 during a trade that took place back on Apr 13, which means that Hack Andrew A. F. is holding 7,737,400 shares at $2,500,000 based on the most recent closing price.
Stock Fundamentals for MRSN
Equity return is now at value -101.40, with -73.50 for asset returns.